In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy

NeuroImage

Volumn 132, Issue , 2016, Pages 104-114

  Jelescu, Ileana O ^a   Zurek, Magdalena ^a   Winters, Kerryanne V ^a   Veraart, Jelle ^a   Rajaratnam, Anjali ^a   Kim, Nathanael S ^a   Babb, James S ^a   Shepherd, Timothy M ^a   Novikov, Dmitry S ^a   Kim, Sungheon G ^a   Fieremans, Els ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Cuprizone; Demyelination; Diffusion MRI; White matter tract integrity

Indexed keywords

CUPRIZONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; G RATIO; IMAGE ANALYSIS; IN VIVO STUDY; MAGNETIZATION TRANSFER RATIO; MEDICAL PARAMETERS; MENTAL PERFORMANCE; MOUSE; MYELIN VOLUME FRACTION; MYELINATED AXONAL WATER FRACTION; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIAL DIFFUSIVITY; TOTAL AXONAL WATER FRACTION; VALIDATION PROCESS; WHITE MATTER TRACT INTEGRITY; ANIMAL; BRAIN MAPPING; C57BL MOUSE; CHEMICALLY INDUCED; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; DIFFUSION; DIFFUSION TENSOR IMAGING; MYELIN SHEATH; PATHOLOGY; PROCEDURES; REMYELINIZATION; ULTRASTRUCTURE;

ANIMALS; BRAIN MAPPING; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON; MYELIN SHEATH; REMYELINATION;

EID: 84959273164     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2016.02.004     Document Type: Article

References (58)

1. Aggarwal M., Mori S., Shimogori T., Blackshaw S., Zhang J. Three-dimensional diffusion tensor microimaging for anatomical characterization of the mouse brain. Magn. Reson. Med. 2010, 64:249-261.
2. Beaulieu C., Allen P.S. Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn. Reson. Med. 1994, 32:579-583.
3. Benitez A., Fieremans E., Jensen J.H., Falangola M.F., Tabesh A., Ferris S.H., Helpern J.A. White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease. NeuroImage Clin. 2013, 4:64-71.
4. Boonstra H., Oosterhuis J.W., Oosterhuis A.M., Fleuren G.J. Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting. Virchows Arch. A Pathol. Anat. Histopathol. 1983, 402:195-201.
5. Brun A., Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 1986, 19:253-262.
6. Collier Q., Veraart J., Jeurissen B., den Dekker A.J., Sijbers J. Iterative reweighted linear least squares for accurate, fast, and robust estimation of diffusion magnetic resonance parameters. Magn. Reson. Med. 2015, 73:2174-2184.
7. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., Buxbaum J., Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 2003, 60:443-456.
8. Falangola M.F., Guilfoyle D.N., Tabesh A., Hui E.S., Nie X., Jensen J.H., Gerum S.V., Hu C., LaFrancois J., Collins H.R., Helpern J.A. Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination. NMR Biomed. 2014, 27:948-957.
9. Fieremans E., Benitez A., Jensen J.H., Falangola M.F., Tabesh A., Deardorff R.L., Spampinato M.V., Babb J.S., Novikov D.S., Ferris S.H., Helpern J.A. Novel white matter tract integrity metrics sensitive to Alzheimer disease progression. AJNR Am J Neuroradiol 2013, 34:2105-2112.
10. Fieremans E., Jensen J.H., Helpern J.A. White matter characterization with diffusional kurtosis imaging. NeuroImage 2011, 58:177-188.
11. Fieremans E., Jensen J.H., Helpern J.A., Kim S., Grossman R.I., Inglese M., Novikov D.S. Diffusion distinguishes between axonal loss and demyelination in brain white matter. Proc. Intl. Soc. Magn. Reson. Med. 2012, 20. (Melbourne, Australia).
12. Fieremans E., Novikov D.S., Jensen J.H., Helpern J.A. Monte Carlo study of a two-compartment exchange model of diffusion. NMR Biomed. 2010, 23:711-724.
13. Filippi M., Preziosa P., Rocca M.A. Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?. Curr. Opin. Neurol. 2014, 27:290-299.
14. Fjaer S., Bo L., Myhr K.M., Torkildsen O., Wergeland S. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochem. Int. 2015, 83-84:28-40.
15. Flurkey K., Currer J.M., Harrison D.E. The mouse in aging research. The Mouse in Biomedical Research 2007, 637-672. Elsevier, Burlington, MA. J.G.E.A. Fox (Ed.).
16. Galvin R.J., Regan D., Heron J.R. A possible means of monitoring the progress of demyelination in multiple sclerosis: effect of body temperature on visual perception of double light flashes. J. Neurol. Neurosurg. Psychiatry 1976, 39:861-865.
17. Gareau P.J., Rutt B.K., Karlik S.J., Mitchell J.R. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J. Magn. Reson. Imaging 2000, 11:586-595.
18. Grossman E.J., Kirov I.I., Gonen O., Novikov D.S., Davitz M.S., Lui Y.W., Grossman R.I., Inglese M., Fieremans E. N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI. NeuroImage 2015, 118:334-343.
19. Grossman R.I., McGowan J.C. Perspectives on multiple sclerosis. AJNR Am. J. Neuroradiol. 1998, 19:1251-1265.
20. Guglielmetti C., Veraart J., Roelant E., Mai Z., Daans J., Van Audekerke J., Naeyaert M., Vanhoutte G., Delgado y Palacios R., Praet J., Fieremans E., Ponsaerts P., Sijbers J., Van der Linden A., Verhoye M. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination. NeuroImage 2016, 125:363-377.
21. Hommes O.R. Remyelination in human CNS lesions. Prog. Brain Res. 1980, 53:39-63.
22. Hui E.S., Fieremans E., Jensen J.H., Tabesh A., Feng W., Bonilha L., Spampinato M.V., Adams R., Helpern J.A. Stroke assessment with diffusional kurtosis imaging. Stroke 2012, 43:2968-2973.
23. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131:1464-1477.
24. Jelescu I.O., Veraart J., Adisetiyo V., Milla S.S., Novikov D.S., Fieremans E. One diffusion acquisition and different white matter models: how does microstructure change in human early development based on WMTI and NODDI?. NeuroImage 2015, 107:242-256.
25. Jelescu I.O., Veraart J., Fieremans E., Novikov D.S. Degeneracy in model parameter estimation for multi-compartmental diffusion in neuronal tissue. NMR Biomed. 2016, 29(1):33-47.
26. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 2002, 17:825-841.
27. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
28. Jensen J.H., Helpern J.A., Ramani A., Lu H., Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn. Reson. Med. 2005, 53:1432-1440.
29. Kelm N.D., West K.L., Carson R.P., Gochberg D.F., Ess K.C., Does M.D. Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains. NeuroImage 2016, 124:612-626.
30. Kinnunen K.M., Greenwood R., Powell J.H., Leech R., Hawkins P.C., Bonnelle V., Patel M.C., Counsell S.J., Sharp D.J. White matter damage and cognitive impairment after traumatic brain injury. Brain 2011, 134:449-463.
31. Klawiter E.C., Schmidt R.E., Trinkaus K., Liang H.F., Budde M.D., Naismith R.T., Song S.K., Cross A.H., Benzinger T.L. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. NeuroImage 2011, 55:1454-1460.
32. Klein S., Staring M., Murphy K., Viergever M.A., Pluim J.P. elastix: a toolbox for intensity-based medical image registration. IEEE Trans. Med. Imaging 2010, 29:196-205.
33. Lamantia A.S., Rakic P. Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J. Comp. Neurol. 1990, 291:520-537.
34. Lamprecht M.R., Sabatini D.M., Carpenter A.E. CellProfiler: free, versatile software for automated biological image analysis. Biotechniques 2007, 42:71-75.
35. Lazar M., Miles L.M., Babb J.S., Donaldson J.B. Axonal deficits in young adults with high functioning autism and their impact on processing speed. NeuroImage Clin. 2014, 4:417-425.
36. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., Chen L., Chen L., Chen T.M., Chin M.C., Chong J., Crook B.E., Czaplinska A., Dang C.N., Datta S., Dee N.R., Desaki A.L., Desta T., Diep E., Dolbeare T.A., Donelan M.J., Dong H.W., Dougherty J.G., Duncan B.J., Ebbert A.J., Eichele G., Estin L.K., Faber C., Facer B.A., Fields R., Fischer S.R., Fliss T.P., Frensley C., Gates S.N., Glattfelder K.J., Halverson K.R., Hart M.R., Hohmann J.G., Howell M.P., Jeung D.P., Johnson R.A., Karr P.T., Kawal R., Kidney J.M., Knapik R.H., Kuan C.L., Lake J.H., Laramee A.R., Larsen K.D., Lau C., Lemon T.A., Liang A.J., Liu Y., Luong L.T., Michaels J., Morgan J.J., Morgan R.J., Mortrud M.T., Mosqueda N.F., Ng L.L., Ng R., Orta G.J., Overly C.C., Pak T.H., Parry S.E., Pathak S.D., Pearson O.C., Puchalski R.B., Riley Z.L., Rockett H.R., Rowland S.A., Royall J.J., Ruiz M.J., Sarno N.R., Schaffnit K., Shapovalova N.V., Sivisay T., Slaughterbeck C.R., Smith S.C., Smith K.A., Smith B.I., Sodt A.J., Stewart N.N., Stumpf K.R., Sunkin S.M., Sutram M., Tam A., Teemer C.D., Thaller C., Thompson C.L., Varnam L.R., Visel A., Whitlock R.M., Wohnoutka P.E., Wolkey C.K., Wong V.Y., Wood M., Yaylaoglu M.B., Young R.C., Youngstrom B.L., Yuan X.F., Zhang B., Zwingman T.A., Jones A.R. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
37. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., Grothe C., Baumgartner W., Stangel M. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 2008, 34:105-114.
38. Mason J.L., Langaman C., Morell P., Suzuki K., Matsushima G.K. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol. Appl. Neurobiol. 2001, 27:50-58.
39. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
40. Novikov D.S., Fieremans E. Relating extracellular diffusivity to cell size distribution and packing density as applied to white matter. Proc. Intl. Soc. Mag. Reson. Med. 2012, 20:1829. Melbourne, Australia.
41. Novikov D.S., Jelescu I.O., Fieremans E. From diffusion signal moments to neurite diffusivities, volume fraction and orientation distribution: an exact solution. Proc. Intl. Soc. Mag. Reson. Med. 2015, 23:469. (Toronto, Canada).
42. Oshio K., Feinberg D.A. GRASE (gradient- and spin-echo) imaging: a novel fast MRI technique. Magn. Reson. Med. 1991, 20:344-349.
43. Praet J., Guglielmetti C., Berneman Z., Van der Linden A., Ponsaerts P. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci. Biobehav. Rev. 2014, 47:485-505.
44. Skripuletz T., Gudi V., Hackstette D., Stangel M. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol. Histopathol. 2011, 26:1585-1597.
45. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 2008, 172:1053-1061.
46. Song S.K., Yoshino J., Le T.Q., Lin S.J., Sun S.W., Cross A.H., Armstrong R.C. Demyelination increases radial diffusivity in corpus callosum of mouse brain. NeuroImage 2005, 26:132-140.
47. Steelman A.J., Thompson J.P., Li J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci. Res. 2012, 72:32-42.
48. Stidworthy M.F., Genoud S., Suter U., Mantei N., Franklin R.J. Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 2003, 13:329-339.
49. Thiessen J.D., Zhang Y., Zhang H., Wang L., Buist R., Del Bigio M.R., Kong J., Li X.M., Martin M. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination. NMR Biomed. 2013, 26:1562-1581.
50. Tomioka R., Matsui M. Biomarkers for multiple sclerosis. Intern. Med. 2014, 53:361-365.
51. Turati L., Moscatelli M., Mastropietro A., Dowell N.G., Zucca I., Erbetta A., Cordiglieri C., Brenna G., Bianchi B., Mantegazza R., Cercignani M., Baggi F., Minati L. In vivo quantitative magnetization transfer imaging correlates with histology during de- and remyelination in cuprizone-treated mice. NMR Biomed. 2015, 28:327-337.
52. Vavasour I.M., Laule C., Li D.K., Traboulsee A.L., MacKay A.L. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis?. J. Magn. Reson. Imaging 2011, 33:713-718.
53. Veraart J., Fieremans E., Jelescu I.O., Knoll F., Novikov D.S. Gibbs ringing in diffusion MRI. Magn. Reson. Med. 2015, [Epub ahead of print]. 10.1002/mrm.25866.
54. Veraart J., Sijbers J., Sunaert S., Leemans A., Jeurissen B. Weighted linear least squares estimation of diffusion MRI parameters: strengths, limitations, and pitfalls. NeuroImage 2013, 81:335-346.
55. Wehrl H.F., Bezrukov I., Wiehr S., Lehnhoff M., Fuchs K., Mannheim J.G., Quintanilla-Martinez L., Kohlhofer U., Kneilling M., Pichler B.J., Sauter A.W. Assessment of murine brain tissue shrinkage caused by different histological fixatives using magnetic resonance and computed tomography imaging. Histol. Histopathol. 2015, 30:601-613.
56. Wu Q.Z., Yang Q., Cate H.S., Kemper D., Binder M., Wang H.X., Fang K., Quick M.J., Marriott M., Kilpatrick T.J., Egan G.F. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J. Magn. Reson. Imaging 2008, 27:446-453.
57. Xie M., Tobin J.E., Budde M.D., Chen C.I., Trinkaus K., Cross A.H., McDaniel D.P., Song S.K., Armstrong R.C. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 2010, 69:704-716.
58. Zaaraoui W., Deloire M., Merle M., Girard C., Raffard G., Biran M., Inglese M., Petry K.G., Gonen O., Brochet B., Franconi J.M., Dousset V. Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T. MAGMA 2008, 21:357-362.